Author: admin

  • How to Stream ‘It’s Always Sunny in Philadelphia’ Season 17

    How to Stream ‘It’s Always Sunny in Philadelphia’ Season 17

    Frank Reynolds as The Golden Bachelor? A second Abbott Elementary crossover from the viewpoint of the Gang? The upcoming 17th season of It’s Always Sunny in Philadelphia looks as eventful as ever, and you can stream it all with a Hulu account. 

    The long-running sitcom returns this week after nearly two years away from screens. Season 17 will see Mac, Charlie, Dennis, Dee and Frank “return to shamelessly shed their ‘niche’ label for grander aspirations,” according to a press release. A trailer shows Frank being his unfiltered self alongside IRL reality dating host Jesse Palmer, plus Dennis getting smelly to appeal to women, ambulances, fires and other forms of chaos. 

    To see all the trouble the Gang gets into this season — and if Frank finds love on a TV show within a TV show — here are the release details for season 17.

    When to watch season 17 of ‘It’s Always Sunny’ on Hulu

    Episodes 1 and 2 of season 17 will air on FXX on July 9 and stream on Hulu the next day, July 10, according to FX. If you want to know Hulu drop dates for the rest of the season, here’s a full schedule.

    • Episode 1, The Gang F***s Up Abbott Elementary: Premieres on FXX on July 9 at 9 p.m. ET/9 p.m. PT. Streams on Hulu July 10.
    • Episode 2, Frank Is in a Coma: Premieres on FXX on July 9 after episode 1. Streams on Hulu July 10.
    • Episode 3, Mac and Dennis Become EMTs: Premieres on FXX on July 16 at 9 p.m. ET/9 p.m. PT. Streams on Hulu July 17.
    • Episode 4, Thought Leadership: A Corporate Conversation: Premieres on FXX on July 23 at 9 p.m. ET/9 p.m. PT. Streams on Hulu July 24.
    • Episode 5, The Gang Goes to a Dog Track: Premieres on FXX on July 30 at 9 p.m. ET/9 p.m. PT. Streams on Hulu July 31.
    • Episode 6, Overage Drinking: A National Concern: Premieres on FXX on Aug. 6 at 9 p.m. ET/9 p.m. PT. Streams on Hulu Aug. 7.
    • Episode 7, The Gang Gets Ready for Prime Time: Premieres on FXX on Aug. 13 at 9 p.m. ET/9 p.m. PT. Streams on Hulu Aug. 14.
    • Episode 8, The Golden Bachelor Live: Premieres on FXX on Aug. 20 at 9 p.m. ET/9 p.m. PT. Streams on Hulu Aug. 21.

    If you’re OK with seeing some ads during your shows, you can sign up for Hulu for $10 per month, or $100 per year. You can avoid commercials with the more expensive version of Hulu, which is $19 per month with no annual payment option.

    James Martin/CNET

    You can get a standalone subscription to Hulu or bundle it with other services. You can choose a combo of a) Hulu and Disney Plus, b) Hulu, Disney Plus and ESPN Plus or c) Hulu, Disney Plus and Max. Hulu free trials and student discounts are also available.


    Continue Reading

  • ‘We were astonished by the success’

    ‘We were astonished by the success’

    By Anna Shvets

    Groundbreaking research by the University of Sydney has identified a new brain protein involved in the development of Parkinson’s disease and a way to modify it, paving the way for future treatments for the disease.

    With the aim of finding new treatments to slow or stop its progression, the research team has spent more than a decade studying the biological mechanisms underpinning the condition—which is the second most common neurological condition after dementia.

    In 2017, they identified for the first time the presence of an abnormal form of a protein—called SOD1—in the brains of patients diagnosed with Parkinson’s disease.

    Normally, the SOD1 protein provides protective benefits to the brain, but in Parkinson’s patients it becomes faulty, causing the protein to clump and damage brain cells.

    The newest study by the same team, led by Professor Kay Double from the Brain and Mind Centre, was just published in Acta Neuropathologica Communications. It found that targeting the faulty SOD1 protein with a drug treatment using copper improved the motor function in mice.

    “We hoped that by treating this malfunctioning protein, we might be able to improve the Parkinson-like symptoms in the mice we were treating – but even we were astonished by the success of the intervention,” said Professor Double in a media release.

    “All the mice we treated saw a dramatic improvement in their motor skills, which is a really promising sign that it could be effective in treating people who have Parkinson disease too.

    ALSO CHECK OUT: First Advanced Parkinson’s Patient to Walk Again with New Spinal Implant, ‘It’s Incredible’

    The study involved two groups of mice with Parkinson-like symptoms. One group was treated with a special copper supplement for three months, while the other received a placebo.

    Throughout the study (which was partly funded by the Michael J. Fox Foundation), the mice receiving only the placebo saw a decline in their motor symptoms. The mice receiving the special copper supplement, however, did not develop movement problems.

    “The results were beyond our expectations,” said Prof. Double. “They suggest, once further studies are carried out, this treatment approach could slow the progression of Parkinson’s disease in humans.”

    At present there is no known cure and only limited treatments for Parkinson’s disease, which is a degenerative disorder in which dopamine-producing cells in the brain die, leading to a range of symptoms including tremors, muscle stiffness, slow movement and impaired balance.

    But researchers hope understanding the causes of the disease will lead to improved treatments.

    MORE GOOD NEWS FOR PATIENTS:
    • Severe Shaking in Parkinson’s Patient Calms Down in Just 6 Days With New Drug –Watch the Transformation
    • Parkinson’s Disease Symptoms ‘Reversed’ by Mini Implant Bringing Hope

    “As our understanding of Parkinson’s disease grows, we are finding that there are many factors contributing to its development and progression in humans – and faulty forms of the SOD1 protein is likely one of them.

    “Just as researchers found with HIV, Parkinson’s disease is a complex condition that likely requires multiple interventions. A single treatment may have a small effect when used alone but, when combined with other interventions, contributes to a significant overall improvement in health.”

    The researchers’ next step is to identify the best approach to targeting the faulty SOD1 protein in a clinical trial, which could be the start of a new therapy to slow the development of Parkinson’s disease.

    CELEBRATE THE BREAKTHROUGH By Sharing on Social Media…


    Continue Reading

  • Lena Dunham Understands Lack of Diversity on Girls Was ‘Disappointing’

    Lena Dunham Understands Lack of Diversity on Girls Was ‘Disappointing’

    Lena Dunham said she now understands why the lack of diversity on her hit HBO show Girls was “really disappointing to people.”

    The coming-of-age comedy-drama, which ran for six seasons from 2012 to 2017, was previously criticized for its characters not accurately representing New York City’s diverse population. The creator and star defended the series in 2012, saying she’s “half-Jew, half-WASP” and wanted to avoid “tokenism in casting.”

    More than a decade after Girls first premiered, Dunham recently reflected on the show, telling The Independent, “I think one of the profound issues around Girls was that there was so little real estate for women in television that if you had a show called Girls, which is such a monolithic name, it sounds like it’s describing all the girls in all the places. And so if it’s not reflecting a multitude of experiences, I understand how that would be really disappointing to people.”

    Girls, which also starred Allison Williams, Jemima Kirke, Adam Driver, Zosia Mamet and Alex Karpovsky, followed the lives of a group of young women in their early twenties as they navigated life, love and careers in New York City.

    Dunham added that she appreciated “the conversation around Girls” and that it helped her make sure her new show Too Much, which sees her serving as producer, writer and director, featured different perspectives and experiences.

    “The thing I have really come to believe is that one of the most important things is not just diversity in front of the camera, but it’s diversity behind the camera,” she explained. “As a producer, one of my goals is to bring a lot of different voices into a position where they can tell their story.”

    Too Much, which stars Megan Stalter and Will Sharpe, follows New York workaholic Jessica, who moves to London planning on being alone following a breakup, only to meet Felix, who causes her to reconsider finding love again. The show debuts on Netflix July 10.

    Continue Reading

  • World Boxing Cup Kazakhstan 2025: Jaismine Lamboria, Sakshi and Nupur win gold as India finish with 11 medals

    World Boxing Cup Kazakhstan 2025: Jaismine Lamboria, Sakshi and Nupur win gold as India finish with 11 medals

    Women boxers led from the front as Olympian Jaismine Lamboria (57kg), Sakshi (54kg) and Nupur (80+kg) won gold in their respective weight classes to help India finish with 11 medals at the World Boxing Cup Kazakhstan 2025 in Astana on Sunday.

    The Indian boxing contingent’s tally from the Astana meet comprised three gold, five silver and three bronze.

    Two-time youth world champion Sakshi was at her best against USA’s Yoseline Perez to get a unanimous verdict from the judges in the women’s 54kg final. It was India’s first gold medal from the Astana boxing meet.

    Paris 2024 Olympian Jaismine Lamboria kept her cool under pressure to get the better of two-time Olympian Jucielen Romeu of Brazil 4-1 in the women’s 57kg weight category. The Indian boxer used her long reach to good effect in the third round after a close opening two rounds.

    Nupur, meanwhile, overcame the challenge of local boxer Yeldana Talipova to earn a 5-0 verdict in the 80+kg final.

    Earlier, Meenakshi pushed hard for victory against local favourite Nazym Kyzaibay, an Olympic bronze medallist, in the 48kg final but ended on the wrong side of a 3-2 verdict.

    Jugnoo (men’s 85kg), Olympian Pooja Rani (women’s 80kg), Hitesh Gulia (men’s 70kg) and Abhinash Jamwal (men’s 65kg) also returned home with silver medals after losing their respective finals.

    Jugnoo lost 5-0 to Bekzad Nurdauletov of Kazakhstan while Pooja went down by an identical scoreline to Australia’s Eseta Flint.

    In the evening session, Hitesh lost 5-0 against Brazil’s Kaian Oliveira and Jamwal suffered a 3-2 split decision defeat against Yuri Falcao.

    Meanwhile, Sanju (women’s 60kg), Nikhil Dubey (men’s 75kg) and Narender Berwal (men’s 90+kg) bagged a bronze medal each, having made it all the way to the semi-finals.

    Indian pugilists had won six medals at the previous World Boxing Cup leg held in Brazil back in April. The Indian women did not compete in Brazil on account of the national championships.

    Boxers accumulate ranking points through their performances at these two meets, with the top pugilists qualifying for the World Boxing Cup Finals to be hosted at New Delhi, India, in November.

    Over 400 boxers from 31 countries, including Olympians, competed at the Kazakhstan leg. India had sent a 20-member team for the Astana meet.

    World Boxing Cup Kazakhstan 2025: Indian medal winners

    • Sakshi (women’s 54kg) – gold medal
    • Jaismine Lamboria (women’s 57kg) – gold medal
    • Nupur (women’s 80+ kg) – gold medal
    • Meenakshi (women’s 48kg) – silver medal
    • Pooja Rani (women’s 80kg) – silver medal
    • Abhinash Jamwal (men’s 65kg) – silver medal
    • Hitesh Gulia (men’s 70kg) – silver medal
    • Jugnoo (men’s 85kg) – silver medal
    • Sanju (women’s 60kg) – bronze medal
    • Nikhil Dubey (men’s 75kg) – bronze medal
    • Narender Berwal (men’s 90+ kg) – bronze medal

    Continue Reading

  • Gabriele Minì handed grid penalty following Silverstone Feature Race

    Gabriele Minì handed grid penalty following Silverstone Feature Race

    Following the conclusion of the FIA Formula 2 Feature Race at Silvestone, PREMA Racing driver Gabriele Minì has been handed a post-race penalty.

    During the Feature event, Car 20 of Minì made contact with Car 5, belonging to Oliver Goethe of MP Motorsport at the exit of Turn 3.

    The Stewards reviewed video evidence during the race and found the driver of Car 10 to be wholly to blame for the incident and elected to apply the standard 10-second time penalty.

    But due to Car 10 not finishing the race, the 10-second time penalty is converted into a five-place grid drop for the next race in which the driver competes.

    Continue Reading

  • Stunning Kashif siege sweeps Steelbacks to one side in vital t20 win

    Stunning Kashif siege sweeps Steelbacks to one side in vital t20 win

    Brookes and Singh (1-12) did an excellent job for their side in the middle overs, controlling the run-rate with efficiency.

    Finch returned with gusto, after an excellent recent display in the Rothesay County Championship match against Hampshire, the quick bowler was bowling with pace and aggression, which was rewarded twice in four balls.

    Northants soon found themselves 104-7, as Finch first undid McManus with a textbook yorker, before removing the dangerous Zaib for 17, after a superb piece of fielding in the deep from young star Isaac Mohammed.

    The fast-bowler changed ends, but his success on the day was far from over as he helped himself to another wicket in his final over, finishing with figures of 3-28 from his four-overs.

    Khurram came back to end Sanderson’s cameo of 27 when he sent his stumps cartwheeling, as the Steelbacks’ clawed their way to 152-9 at the completion of their 20 overs.

    The Rapids’ pursuit got off to a far from ideal start, with youngster Isaac Mohammed caught at mid-off in the first over, before D’Oliveira was bowled by Willey in the third over as the away side were pegged back at 3-2.

    Kashif Ali and Gareth Roderick came together and showed positive signs, playing with intent, as Kashif drilled Sanderson back over his head for a big six into the sightscreen.

    The number-four continued his assault, taking Broad’s first over for 18, as the Rapids ended the powerplay 44-2.

    Kashif then stepped up through the gears, as he blasted his way to a second Vitality Blast half-century of the season, reaching the feat in 24 balls and including seven boundaries.

    Roderick began to exhibit his shot-variety, timing the ball to the midwicket boundary at ease as Worcestershire reached the halfway stage of their innings, 89-2.

    Kashif’s display of clean ball-striking provided the visitors innings with exactly the impetus it needed, as he and Roderick notched their 100 partnership off just 52 balls, with Kashif striking at over 200 for almost the entirety of his knock, as he bettered his highest T20 score to date.

    His sublime knock of 88 from just 45 balls was brought to a close when the Rapids number-four mistimed a big shot into the leg-side and was caught on the boundary, 12 runs short of a deserved hundred.

    He departed with his side 130-3 after his 127-run partnership with Roderick left Worcestershire needing just 23 to win from the remaining five overs.

    Roderick fell four-balls later for a well-tempered 36 off 31 balls, as debutant Henry Cullen joined Ethan Brookes at the crease,

     

    Continue Reading

  • Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Kotadia ID, Williams SE, O’Neill M. Supraventricular tachycardia: an overview of diagnosis and management. Clin Med (Lond). 2020;20(1):43–7.

    Article 
    PubMed 

    Google Scholar 

  • Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European society of cardiology (ESC) endorsed by the association for European paediatric and congenital cardiology (AEPC). Eur Heart J. 2022;43(40):3997–4126.

    Article 
    PubMed 

    Google Scholar 

  • Sirichand S, Killu AM, Padmanabhan D, Hodge DO, Chamberlain AM, Brady PA, Kapa S, Noseworthy PA, Packer DL, Munger TM et al. Incidence of idiopathic ventricular arrhythmias: A Population-Based study. Circ Arrhythm Electrophysiol 2017;10(2).

  • Piccini JP, Schulte PJ, Pieper KS, Mehta RH, White HD, Van de Werf F, Ardissino D, Califf RM, Granger CB, Ohman EM, et al. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction*. Crit Care Med. 2011;39(1):78–83.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Soar J, Böttiger BW, Carli P, Couper K, Deakin CD, Djärv T, Lott C, Olasveengen T, Paal P, Pellis T, et al. European resuscitation Council guidelines 2021: adult advanced life support. Resuscitation. 2021;161:115–51.

    Article 
    PubMed 

    Google Scholar 

  • Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, De Potter TJR, Dwight J, Guasti L, Hanke T, et al.: 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS): developed by the task force for the management of atrial fibrillation of the European society of cardiology (ESC), with the special contribution of the European heart rhythm association (EHRA) of the ESC. Endorsed by the European stroke organisation (ESO). Eur Heart J. 2024;45(36):3314–414.

    Article 
    PubMed 

    Google Scholar 

  • Bedford JP, Johnson A, Redfern O, Gerry S, Doidge J, Harrison D, Rajappan K, Rowan K, Young JD, Mouncey P, et al. Comparative effectiveness of common treatments for new-onset atrial fibrillation within the ICU: accounting for physiological status. J Crit Care. 2022;67:149–56.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Walkey AJ, Evans SR, Winter MR, Benjamin EJ. Practice patterns and outcomes of treatments for atrial fibrillation during sepsis: A Propensity-Matched cohort study. Chest. 2016;149(1):74–83.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Balik M, Kolnikova I, Maly M, Waldauf P, Tavazzi G, Kristof J. Propafenone for supraventricular arrhythmias in septic shock—Comparison to Amiodarone and Metoprolol. J Crit Care. 2017;41:16–23.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Fatima N, Mandava K, Khatoon F, Badar J, Begum SF, Narasimhan C, Daljeet K, Mohammed W. CLInical profile and side effects of chronic use of oral Amiodarone in cardiology outpatients department (CLIPSE-A Study)- A prospective observational study. Annals Med Surg. 2022;80:104167.

    Article 

    Google Scholar 

  • Drikite L, Bedford JP, O’Bryan L, Petrinic T, Rajappan K, Doidge J, Harrison DA, Rowan KM, Mouncey PR, Young D, et al. Treatment strategies for new onset atrial fibrillation in patients treated on an intensive care unit: a systematic scoping review. Crit Care. 2021;25(1):257.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Medić F, Bakula M, Alfirević M, Bakula M, Mucić K, Marić N. AMIODARONE AND THYROID DYSFUNCTION. Acta Clin Croat. 2022;61(2):327–41.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Ruzieh M, Moroi MK, Aboujamous NM, Ghahramani M, Naccarelli GV, Mandrola J, Foy AJ. Meta-Analysis comparing the relative risk of adverse events for Amiodarone versus placebo. Am J Cardiol. 2019;124(12):1889–93.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomström-Lundqvist C, Calkins H, Corrado D, Deftereos SG, Diller G-P, et al. 2019 ESC guidelines for the management of patients with supraventricular tachycardiathe task force for the management of patients with supraventricular tachycardia of the European society of cardiology (ESC): developed in collaboration with the association for European paediatric and congenital cardiology (AEPC). Eur Heart J. 2019;41(5):655–720.

    Article 

    Google Scholar 

  • Gorre F, Vandekerckhove H. Beta-blockers: focus on mechanism of action. Which beta-blocker, when and why? Acta Cardiol. 2010;65(5):565–70.

    Article 
    PubMed 

    Google Scholar 

  • Wong GWK, Boyda HN, Wright JM. Blood pressure Lowering efficacy of beta-1 selective beta blockers for primary hypertension. Cochrane Database Syst Reviews 2016;(3).

  • Gorczynski RJ, Shaffer JE, Lee RJ. Pharmacology of ASL-8052, a novel β-Adrenergic receptor antagonist with an ultrashort duration of action. J Cardiovasc Pharmacol. 1983;5(4):668–77.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Wiest D. Esmolol. A review of its therapeutic efficacy and Pharmacokinetic characteristics. Clin Pharmacokinet. 1995;28(3):190–202.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi K, Sakaki K, Hachiya K, Ichioka Y, Kawamura M. Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101. Chem Pharm Bull (Tokyo). 1992;40(6):1462–9.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Atarashi H, Kuruma A, Yashima M, Saitoh H, Ino T, Endoh Y, Hayakawa H. Pharmacokinetics of Landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther. 2000;68(2):143–50.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Krumpl G, Ulc I, Trebs M, Kadlecová P, Hodisch J. Pharmacokinetics and pharmacodynamics of two different Landiolol formulations in a healthy Caucasian group. Eur J Pharm Sci. 2016;92:64–73.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Iwahashi N, Takahashi H, Abe T, Okada K, Akiyama E, Matsuzawa Y, Konishi M, Maejima N, Hibi K, Kosuge M, et al. Urgent control of rapid atrial fibrillation by Landiolol in patients with acute decompensated heart failure with severely reduced ejection fraction. Circ Rep. 2019;1(10):422–30.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Schnaubelt S, Eibensteiner F, Oppenauer J, Tihanyi D, Neymayer M, Brock R, Kornfehl A, Veigl C, Al Jalali V, Anders S et al. Hemodynamic and rhythmologic effects of Push-Dose Landiolol in critical Care-A retrospective Cross-Sectional study. Pharmaceuticals (Basel) 2023;16(2).

  • Johnston BW, Chean CS, Duarte R, Hill R, Blackwood B, McAuley DF, Welters ID. Management of new onset atrial fibrillation in critically unwell adult patients: a systematic review and narrative synthesis. Br J Anaesth. 2022;128(5):759–71.

    Article 
    PubMed 

    Google Scholar 

  • Van Gelder IC, Hemels MEW. The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm. EP Europace. 2006;8(11):943–9.

    Article 

    Google Scholar 

  • Gupta D, Rienstra M, van Gelder IC, Fauchier L. Atrial fibrillation: better symptom control with rate and rhythm management. Lancet Reg Health – Europe. 2024;37:100801.

    Article 
    PubMed 

    Google Scholar 

  • Levy B, Slama M, Lakbar I, Maizel J, Kato H, Leone M, Okada M. Landiolol for treatment of New-Onset atrial fibrillation in critical care: A systematic review. J Clin Med. 2024;13(10):2951.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Krumpl G, Ulc I, Trebs M, Kadlecová P, Hodisch J. Bolus application of Landiolol and esmolol: comparison of the Pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group. Eur J Clin Pharmacol. 2017;73(4):417–28.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Bucci T, Proietti R, Lip GYH. Risk of death and thromboembolic events in patients with supraventricular arrhythmias admitted to the emergency department. EP Europace 2024;. Volume 26, Issue Supplement_1, May 2024, euae102.833

  • Fornage LB, Christine ON, DS R, WE R, LR S, Brown LH. Prehospital intervention improves outcomes for patients presenting in atrial fibrillation with rapid ventricular response. Prehospital Emerg Care. 2024;28(7):910–9.

    Article 

    Google Scholar 

  • Nasoufidou A, Papazoglou AS, Stachteas P, Karagiannidis E, Samaras A, Alexiou S, Mourtzos MA, Kassimis G, Fragakis N. Intravenous Landiolol for rate control in supraventricular tachyarrhythmias in patients with left ventricular dysfunction: A systematic review and Meta-Analysis. J Clin Med 2024, 13(6).

  • Heliste M, Pettilä V, Berger D, Jakob SM, Wilkman E. Beta-blocker treatment in the critically ill: a systematic review and meta-analysis. Ann Med. 2022;54(1):1994–2010.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Whitehouse T, Hossain A, Perkins GD, Gordon AC, Bion J, Young D, McAuley D, Singer M, Lord J, Gates S et al. Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial. JAMA 2023.

  • Rehberg S, Frank S, Černý V, Cihlář R, Borgstedt R, Biancofiore G, Guarracino F, Schober A, Trimmel H, Pernerstorfer T, et al. Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP). Intensive Care Med. 2024;50(10):1622–34.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Schnaubelt S, Eibensteiner F, Sulzgruber P. Landiolol in septic Shock — No One-Size-Fits-All approach. Heart Lung Circulation. 2024;33(4):e31–2.

    Article 
    PubMed 

    Google Scholar 

  • Hariri G, Urbina T, Mazerand S, Bige N, Baudel JL, Ait-Oufella H. Rate control in atrial fibrillation using Landiolol is safe in critically ill Covid-19 patients. Crit Care. 2021;25(1):33.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ditali V, Garatti L, Morici N, Villanova L, Colombo C, Oliva F, Sacco A. Effect of Landiolol in patients with tachyarrhythmias and acute decompensated heart failure (ADHF): a case series. ESC Heart Fail. 2022;9(1):766–70.

    Article 
    PubMed 

    Google Scholar 

  • Novotny J, Klein MM, Haum M, Fichtner SR, Thienel MB. Prevalence of pathological arrhythmia in patients triaged to cardiac arrhythmia in the emergency department: a preliminary study. Int J Emerg Med. 2022;15(1):49.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Smith G, McD Taylor D, Morgans A, Cameron P. Prehospital management of supraventricular tachycardia in victoria, australia: epidemiology and effectiveness of therapies. Emerg Med Australasia. 2014;26(4):350–5.

    Article 

    Google Scholar 

  • Fornage LB, O’Neil C, Dowker SR, Wanta ER, Lewis RS, Brown LH. Prehospital intervention improves outcomes for patients presenting in atrial fibrillation with rapid ventricular response. Prehospital Emerg Care. 2024;28(7):910–9.

    Article 

    Google Scholar 

  • Berkenbush M, Sherman N, Jain N, Cosmi P. Prehospital treatment of atrial fibrillation: infusion pump for bolus and infusion? Prehospital Emerg Care:1–4.2025;29(1):85-88. https://doi.org/10.1080/10903127.2024.2349745. Epub 2024 May 21.

  • Ball J, Mahony E, Nehme E, Voskoboinik A, Hogarty J, Dawson LP, Horrigan M, Kaye DM, Stub D, Nehme Z. The burden of atrial fibrillation on emergency medical services: A population-based cohort study. Int J Cardiol. 2024;414:132397.

    Article 
    PubMed 

    Google Scholar 

  • Vásquez-Tirado GA, Quispe-Castañeda CV, Meregildo-Rodríguez ED, Cuadra-Campos M, Segura-Plasencia NM, Arbayza-Avalos YK, Alva-Guarniz HN, Guzmán-Aguilar WM, Zavaleta-Alaya P. Association of beta blockers and mortality in adults with septic shock: systematic review and meta-analysis of randomized clinical trial. Front Med 2024;Sep 24:11:1448573; eCollection 2024.

Continue Reading

  • Hsp47 drives obesity-associated breast cancer progression by enhancing asporin deposition in adipose tissue | Breast Cancer Research

    Hsp47 drives obesity-associated breast cancer progression by enhancing asporin deposition in adipose tissue | Breast Cancer Research

    Transgenic mice

    We generated adipocyte-specific knockout Hsp47 mice by crossing Hsp47 Loxp/Loxp mice with Adipoq-cre mice (Jackson Lab, 010803). Asporin knock-out mice are from Dr. Paula Hurley at Vanderbilt University. Tail tip samples were collected for DNA isolation and genotyping PCR between 14 and 21 days after born. Genotyping PCR was performed using the 2X Mater Mixer and primers listed in the Supplemental Table. Female C57BL/6 mice, or Hsp47 adipocyte-specifically knockout (Hsp47 Adi-KO) or asporin KO female litter mates were randomly mixed and grouped for the xenograft experiments. All the mice were housed under 12/12 light/darkness cycles with free access to diet and water in the Division of Laboratory Animal Resources at the University of Kentucky. All procedures were performed with Division of Laboratory Animal Resources guidelines at the University of Kentucky.

    Human and mouse cell lines and cell line classification

    The human breast cancer cell lines MDA-MB 231 and human embryonic kidney cell line HEK293T were obtained from American Type Culture Collection (ATCC). Mouse breast cancer cell lines EO771 was obtained from ATCC. MDA-MB 231 cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM)/F12 (Sigma Aldrich, D8437) with 10% fetal bovine serum (FBS) (Sigma Aldrich, F2442), 10 units/ml of penicillin and 0.1 mg/ml of streptomycin (Sigma, P4333). HEK293 FT cells were maintained in DMEM (Sigma Aldrich, D6429) with 10% FBS (Sigma Aldrich), 10 units/ml of penicillin, and 0.1 mg/ml of streptomycin (Invitrogen). EO771 cells were maintained in RPMI-1640 (Sigma Aldrich, R8758) with 10% FBS (Sigma Aldrich), 10 mM HEPES, 10 units/ml of penicillin, and 0.1 mg/ml of streptomycin (Invitrogen). Mouse 3T3-L1 cells were maintained in DMEM (Sigma Aldrich) with 10% Newborn calf serum (NCS) (Sigma, N4762), 10 units/ml of penicillin, and 0.1 mg/ml of streptomycin (Invitrogen). All the cells were cultured at 5% CO2 and 95% O2 at 37 °C. All cells were treated with Plasmocin™ (Invivo Gen, ant-mpt-1) to eliminate and prevent mycoplasma contamination.

    Kaplan-meier survival analysis and association analysis

    To address the clinical relevance of enhanced Asporin expression, we assessed the association between asporin mRNA levels and TNBC patient survival using Breast Cancer Gene-Expression Miner with multiple published datasets [24]. Tumor samples were equally grouped into low and high asporin expression based on the mRNA levels. The Cox proportional hazard (log-rank) test assessed significant differences in recurrent-free survival ratio. The correlation between Hsp47 expression and asporin was analyzed using the public microarray dataset generated from human breast cancer tissues.

    DNA constructs, transfection, and viral transduction

    SERPINH1 cDNA was cloned into pCDH1 plasmid and generated expression vector pCDH1-Hsp47 [23]. Flag-tagged mouse asporin full cDNA and truncated asporin cDNA (Mutant 1, Mutant 2) were sub-cloned from pCMV3-Asporin-FLAG (Sino Biological, Supplemental Table) into pCDH1 plasmid and generated expression vector pCDH1-Asporin (WT)-Flag, pCDH1-Asporin (MT1)-Flag and pCDH1-Asporin (MT2)-Flag. Mouse SERPINH1 Knockdown plasmids shHsp47 (Target Sequence: CGAACACTCCAAGATCAACTT, TRCN0000008532) were purchased from Sigma. HEK293 cells were transfected with pCDH1-Hsp47 and pCDH1-Asporin (WT)-Flag/pCDH1-Asporin (MT1)-Flag/pCDH1-Asporin (MT2)-Flag using FuGENE® HD Transfection Reagent (Promega, E2312). Cell lysis was collected for immunoprecipitation assay 48 h after transfection.

    Immunoblotting analysis

    Total tissue protein was isolated from adipocyte tissue using Minute™ Total Protein Extraction Kit (Invent, AT-022). Deposited ECM protein was isolated from culture cells using Compartment Protein Extraction Kit (Sigma, 2145). Culture cells were lysed in 2% SDS in PBS buffer containing phosphatase and protease inhibitor cocktails (EMD Millipore, 539131). Conditioned medium was collected at 24 h after being replaced with plan medium and precipitated by Acetone. Protein concentration was measured using Pierce™ BCA Protein Assay Kit (Thermo Fisher Scientific, 23225). Equal amounts of protein lysates or cell conditional medium (normalized to cell numbers) were subjected to SDS gel electrophoresis, immunoblotted with primary antibodies at 4 °C overnight, and DyLight 680/800-conjugated secondary antibodies for 2 h at room temperature. The secondary antibodies used in the study were: DyLight 680 conjugated goat anti-rabbit IgG secondary antibody (Thermo Fisher Scientific, 35569), DyLight 800 conjugated goat anti-mouse IgG secondary antibody (Thermo Fisher Scientific, SA5-35521), DyLight 680 conjugated donkey anti-goat IgG secondary antibody (Thermo Fisher Scientific, SA5-10090). The primary antibodies used in this study were listed in Supplemental Table.

    Reverse transcription-polymerase chain reaction (RT-PCR)

    Total RNA was extracted from adipocyte tissue of control or Hsp47 Adi-KO mice using TRIzol reagent (Invitrogen, 15-596-018). cDNA was synthesized using the SuperScript™ III First-Strand Synthesis System (Invitrogen, 18-080-051) from 1.0 µg RNA samples. RT-PCRs were performed using Taq DNA polymerase on the C1000 Touch Thermo Cycler (Bio-Rad). Thermal cycling was conducted at 95 °C for 60 s, followed by 40 cycles of amplification at 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 15 s. PCR products were performed agarose gel electrophoresis using 2% Agarose in TAE buffer (40 mM Tris-acetate, 1 mM EDTA). Information of primers used for amplification SERPINH1, β-Tubulin, and 18 S rRNA is in Supplemental Table.

    Special diet feeding

    3-week old males and females carrying different genotypes (Adipo-Cre/HSP47Loxp/Loxp, Adipo-Cre/HSP47Loxp/+, Adipo-Cre/HSP47+/+) were fed with a low-fat diet (LFD, 10 kcal% fat, Research Diets, D12450B) or high-fat diet (HFD, 60 kcal% fat, Research Diets, D12492). This special diet was renewed every week, and the changes in food weight were weighed for measuring the food intake of the mice. The body weights of mice with LFD were measured every week during the 12-week feeding period, and the body weights of mice with HFD were measured every week during the 20-week feeding period.

    Glucose measurement and glucose tolerance tests

    HFD-fed mice with different genotypes fasted for 6 h in the morning for glucose measurements. The tail vein was lanced with the lancet and a drop of blood from the tail was read as the baseline glucose level. For the glucose tolerance test, 6 h fasted mice were intraperitoneally injected with Glucose (2 g/kg body weight, 10 ml/kg volume). Blood glucose was measured at 15 min, 30 min, 60 min, 90 min, and 120 min after injection.

    Serum insulin measurement

    HFD-fed mice with different genotypes fasted for 6 h in the morning for insulin level measure. The tail vein was lanced with the lancet. Round 50 µl blood sample was collected and centrifuged for at least 15 min at 2200–2500 RPM within one hour of collection. Then the serum was transferred to new EP tubes for insulin levels measurement by the Mouse Ultrasensitive Insulin ELISA kit (ALPCO, 80-INSMSU-E01).

    Calorimetry experiments

    HFD-fed mice with different genotypes were examined the energy expenditure and energy balance via the TSE calorimetry chambers and the EchoMRI. Calorimetry will be performed according to the SOP as described in the 2016–2337 Protocol for The Center of Research in Obesity and Cardiovascular Diseases (COCVD) Mouse Metabolism Core of the University of Kentucky.

    Xenograft studies

    Control, Hsp47 Adi-KO and Asporin KO female mice were weaned at three-week-old and fed with HFD for twelve weeks. The wnt tumor tissue was harvested from mice and digested with collagenase, and the tumor organoids were collected for xenograft experiments. Mice were randomly grouped and injected with 1 × 105 EO771 cells or Wnt organoids at the 4th mammary fat pad. Tumors were measured with a caliper every 2 days to analyze tumor growth. At the experimental endpoint, tumors were harvested and fixed with a 10% Formalin solution for the paraffin-embedded section or frozen in OCT.

    Five-week-old female C57BL/6 mice were fed with HFD for four weeks and randomly grouped and daily injected with vehicle control or 10 mg/kg Col003 by intraperitoneal injection for eight weeks. Mice were injected with 1 × 105 EO771 cells at the 4th mammary fat pad. Tumors were measured with a caliper every 2 days and when tumors reached 60 ~ 70 mm3, mice were treated with vehicle control or 10 mg/kg Col003 daily. At the experimental endpoint, tumors were harvested and fixed with a 10% Formalin solution for the paraffin-embedded section or frozen in OCT for SHG imaging.

    Second harmonic generation (SHG) imaging

    SHG images were collected for adipose and tumor tissue sections through a Zeiss 20× water-dipping objective at 880 nm excitation. A cube filter set containing emission filters SHG (425 nm) was used in on the Zeiss 880 multiphoton microscope equipped with an Insight X3 extended wavelength laser (Spectra Physics, Santa Clara, CA, United States). Images were quantified with ImageJ.

    Masson’s trichrome staining

    Masson’s trichrome staining was performed following the manufacturer’s protocol (Polysciences, 25088). Mammary gland sections from 8-week-old control or Hsp47 Adi-KO female mice were deparaffinized and rehydrated through 100% alcohol, 95% alcohol, and 70% alcohol to water. Samples were re-fixed in Bouin’s solution at 60 °C for 60 min, stained in Weigert’s working hematoxylin for 10 min, and then stained in Biebrich scarlet-acid fuchsin solution for 5 min. Sections were incubated in phosphomolybdic/phosphotungstic acid solution for 10 min, and then were transferred to an aniline blue solution and incubated for 5 min. Then sections were incubated with 1% acetic acid for 1 min and washed in distilled water. Images were taken with a Nikon Eclipse 80i microscope.

    Immunohistochemical staining and H&E staining

    Xenograft tumor sections were deparaffinized and rehydrated through 100% alcohol, 95% alcohol, and 70% alcohol to PBS solution. Endogenous peroxidase was blocked by incubation with 3% H2O2 for 20 min. At the antigen retrieval step, slides were steamed in citrate sodium buffer for 30 min. Slides were blocked with Avidin/Biotin Blocking Kit (Vector Laboratories, SP-2001) and 5% goat serum, incubated with primary antibodies (anti-Hsp47, anti-Ki67, anti-Active Caspase 3, anti-F4/80, Supplemental Table) at 4 °C overnight, and then the sections were incubated with Biotinylated Goat Anti-Mouse IgG Antibody (Vector Laboratories, BA-9200) or Biotinylated Goat Anti-Rabbit IgG Antibody (Vector Laboratories, BA-1000) at room temperature for 60 min. After incubated with Streptavidin, Horseradish Peroxidase (Vector Laboratories, SA-5704) at room temperature for 30 min, staining signaling was accomplished after incubated with substrate diaminobenzidine (DAB, Vector Laboratories, SK-4100) and counterstained with hematoxylin. Images were taken with Nikon Eclipse 80i microscope.

    Adipocyte differentiation induction

    3T3-L1 Cells were seeded in a 6-well plate at a density of 6 × 105 cells/well as described in published paper [25]. After 24 h, the culture medium was renewed when cells reached 100% confluence. After 48 h, cell differentiation was induced by changing the medium to differentiation medium I: DMEM containing 10% FBS, 10 units/ml of penicillin, and 0.1 mg/ml of streptomycin, 0.5 mM IBMX, 0.25 µM dexamethasone, and 1 µg/ml insulin, 2 µM rosiglitazone. After 48 h, the medium was changed to differentiation medium II: DMEM containing 10% FBS, 10 units/ml of penicillin and 0.1 mg/ml of streptomycin, and 1 µg/ml insulin. After 48 h, the medium was changed to DMEM containing 10% FBS and 10 units/ml of penicillin and 0.1 mg/ml of streptomycin.

    Flow cytometry analysis

    To analyze adipocyte tissue infiltrated macrophage (Adipocyte tissue macrophages, ATMs), macrophage markers expression in adipocyte tissues were examined by flow cytometry analysis. Immune cells were isolated from adipocyte tissue as previously described [26]. In general, subcutaneous white adipocyte tissues (WAT) were collected from HFD-fed mice and digested by collagenase II digest solution. Stromal vascular cells were incubated with Fc-block (anti-CD16/32) and stained with cell surface markers (Supplemental Table) for 30 min at 4 °C protected from light to identify ATMs. For controls, additional stromal vascular cells are stained with each antibody individually (single stained controls) and the antibody cocktail minus one antibody, fluorescence minus one (FMO controls). Single stained controls and FMO controls were used to set up the compensation matrix and sorting gates. Add an additional 400 ul PBS and kept on ice for FACS analysis. FACS analysis was done with Becton Dickinson LSR II and data were analyzed by FlowJo software.

    Decellularization and ex vivo implantation

    Adult female mammary gland tissues were collected and sliced into 1–2 mm thick pieces, then placed in a sterile 6-well plate and incubated in rinse solution (deionized water with 5x penicillin/streptomycin) for 1 h at 4 °C [27]. Mammary gland tissues were removed from the rinse solution and incubated in 4% sodium deoxycholate (SDC solution) with 1x Pen/Srep for 24 h (change after 12 h) at room temperature to lyse cells. After rinsing 5 times with rinse solution for 1 h, mammary gland tissues were incubated in 8 mM 3-((3-cholamidopropyl)-dimethylammonium)-1-propanesulfonate (CHAPS solution) for 24 h (change after 12 h). Following rinsing 5 times with rinse solution, tissues were incubated in DNase solution (DNase 100 U/mL, with 5 × penicillin/streptomycin) 2 h at room temperature to lyse DNA. Mammary gland tissues were incubated with isopropanol for 24 h (change after 12 h, 4 °C), and then washed with rinse solution (20 min, three times) and stored at − 80 °C. Decellularized mammary gland tissue was cut into 5 mm square cubes and placed in a p-HEMA-coated 24-well plate. 0.2 × 106 MDA-MB 231-Luc cells were seeded on the top of the decellularized mammary gland tissue and incubated at 37 °C, 5% CO2 for 2 h to allow cells to attach. DMEM/F12 medium (1×B27, 20 ng/ml bFGF, 20 ng/ml EGF, 0.5 µg/ml hydrocodison, 5 µg/ml Insulin, 100 µg/ml Gentamicin (Life Technologies, Grand Island, NY, USA)) was carefully added to each well and incubated at 37 °C, 5% CO2 for the desired time. Luminescent intensity of MDA-MB 231-Luc cells attached and grew in the decellularized mammary tissue was measured using an in vivo imaging system (IVIS) on day 5 after seeding.

    IF staining

    Frozen tissue sections were fixed with 4% paraformaldehyde and permeabilized with 0.5% Triton X-100 for 20 min. After being blocked with 10% goat serum at room temperature for 60 min, tissue sections were incubated overnight with primary antibody (anti-Collagen IV) at 4 °C. After being washed three times, tissue sections were incubated in the dark with fluorescent conjugated secondary antibody for 1 h at room temperature. Stained samples were covered with DAPI-containing anti-fade mounting media (Vector labs, H1200-10) and imaged with a Nikon upright epi fluorescence microscope.

    ECM extraction and mass spectrometry analysis

    To enrich the ECM proteins of adipocyte tissues, we isolated ECM proteins from adipocyte tissues using the Compartment Protein Extraction Kit (Sigma, 2145) [28]. In general, WAT(100 mg) from mouse mammary glands were homogenized in 500 µl of Buffer C containing protease inhibitors using a tissue homogenizer until the tissue is completely disrupted. After sequential extraction of intracellular soluble proteins (cytosolic proteins, nuclear proteins, membrane proteins, the cytoskeletal proteins), the ECM-enriched pellets were suspended by adding the appropriate volume of 8 M urea with 10mM DTT. The ECM-enriched samples were alkylated by iodoacetamide, deglycosylated by PNGaseF, as well as digestion by Lys-C and trypsin. The digested samples were quenched with formic acid, concentrated and desalted with Ziptip before injected for MS analysis with a 150 min gradient adapted from literature. MS datasets were searched with Proteome Discoverer (Thermo Scientific) and Mascot version 1.3 (Matrix Science). Mascot search parameters were 10 ppm mass tolerance for precursor ions and 0.8 Da for fragment ions; two missed cleavages of trypsin with dynamic modifications including carbamidomethylation of cdegested ysteine, oxidized methionine, deamidation of asparagine, pyro-glutamic acid modification at N-terminal glutamine, and hydroxylation of lysine and proline.

    Immunoprecipitation assay

    Hsp47 expression plasmid pCDH1-Hsp47 and asporin expression plasmid CDH1-Asporin (WT)-Flag/pCDH1-Asporin (MT1)-Flag/pCDH1-Asporin (MT2)-Flag transfected HEK293 cells were lysed with ice cold hypotonic gentle lysis buffer (10 mM Tris-HCl [pH 7.5], 10 mM NaCl, 2mMEDTA, 0.5% Triton X-100, phosphatase and protease inhibitor cocktails (EMD Millipore, 539131) and incubated on ice for 10 min. 5 M NaCl was added in the cell lysis to 150mM concentration. The protein complexes were pulled down with anti-Flag M2 affinity gel (Sigma Aldrich, A2220), and the immunoprecipitated protein was eluted for immunoblotting analysis.

    DSP experiments

    Formalin-fixed paraffin embedded tissue sections were analyzed using Nanostring’s GeoMx Digital Spatial Profiling platform. All steps were carried out per Nanostring’s demonstrated protocol following manufacturer’s instructions. Slides underwent deparaffinization and antigen retrieval, followed by overnight incubation with Mouse Immune Cell Profiling Protein Core (Nanostring #GMX-PROCO-NCT-MICP-12), as well as anti-pan cytokeratin-AF532 and anti-CD45-AF594 (Nanostring #GMX-PRO-MORPH-MST-12) to visualize tissue sections and aid in region of interest selection. After incubation, slides were post-fixed, and nuclei were stained with Syto 13 before loading slides on the GeoMx instrument for whole slide fluorescent imaging. Regions of interest were selected from each sample and the nucleotide barcodes for panel antibodies bound in the region of interest were cleaved via UV exposure, then aspirated and transferred to a 96 well plate. The sample plate was processed per manufacturer’s instructions and analyzed on the Nanostring Sprint platform. The raw DSP data was normalized by the expression of the housekeeping protein Histone H3 within each ROI, then log2-transformed for downstream statistical analysis. Protein expression profiles of Hsp47 KO vs. Hsp47 pos groups within the tumor-adjacent (T-A) adipose tissue were visualized by heatmap. The linear mixed model with a fixed effect on Hsp47 genotype and a random intercept was applied to compare the Hsp47 KO vs. Hsp47 pos subgroups. The log2-fold change and p-value estimated from the linear mixed model were used to generate volcano plots within tumor and T-A adipose tissues, respectively, where the dots in red represent the proteins with p-value less than 0.05. Boxplots of proteins of interests were generated to manifest the direction of change between the Hsp47 KO vs. Hsp47 pos subgroups.

    Quantification and statistical analysis

    All experiments were repeated at least three times. Results were reported as mean ± standard error of the mean (S.E.M), the significance of difference was assessed by independent Student’s t-test or one-way analysis of variance (ANOVA) with SigmaPlot (Systat Software) or SPSS Statistics (IBM, Statistics). P < 0.05 is considered statistical significance, and P < 0.01 represented sufficient statistical significance. All reported P values were from 2-tailed tests.

    Continue Reading

  • Israeli science joins a global effort: Axiom’s Ax-4 mission

    Israeli science joins a global effort: Axiom’s Ax-4 mission

    Axiom Space’s fourth private mission, Ax-4, launched on June 25 after a series of delays. On June 26, the Dragon spacecraft successfully docked with the International Space Station (ISS), where its four crew members joined the seven astronauts already aboard the station. This Dragon spacecraft carries a new name — Grace — as announced at the time of separation from the upper stage.

    The mission doubles the number of official Indian representatives to have flown in space. Until now, the world’s most populous country had sent only one astronaut — more precisely, a cosmonaut – Rakesh Sharma, who spent a week aboard the Soviet Salyut 7 space station in 1984 as part of Soviet-Indian cooperation. Now, 39-year-old Indian pilot Shubanshu Shukla joins that legacy as a crew member of this private mission and the first Indian citizen to reach the International Space Station.

    5 View gallery

    Preparing to enter a cooling phase until next year. An illustration of the spacecraft during its close approach to the Sun

    Preparing to enter a cooling phase until next year. An illustration of the spacecraft during its close approach to the Sun

    (Photo: Axiom Space)

    As with previous Axiom missions, command was assigned to a professional astronaut — Peggy Whitson, who holds the U.S. record for cumulative time in space at 675 days. A former senior NASA astronaut, Whitson joined Axiom after retiring from the agency. Axiom has been selected to develop a private space station to eventually replace the ISS, which is expected to retire by the end of the decade. For Whitson, 65, this marks her fifth visit to the space station, her second with Axiom — and possibly not her last.

    In addition to Whitson, the crew includes representatives from national space agencies, each from a country that previously sent only one astronaut to space during the Soviet era. Engineer Sławosz Uznański-Wiśniewski of the European Space Agency becomes Poland’s second astronaut, while 35-year-old engineer Tibor Kapu is Hungary’s second official astronaut. Hungary’s first unofficial representative was space tourist Charles Simonyi, a Hungarian-American entrepreneur who flew to the ISS twice — in 2007 and 2009 — on privately funded missions.

    Hungary is also collaborating in the continuation of Israeli research focused on detecting lightning sprites and other atmospheric phenomena. In experiments led by Prof. Yoav Yair of Reichman University, astronauts attempt to photograph these colorful, spectacular bursts of light that occur above thunderstorms.

    Though massive in scale, they often last only fractions of a second. Capturing them requires astronauts to aim their cameras with exceptional precision at active storm systems. This is made possible by data provided by Yair, who cross-references detailed storm forecasts with the space station’s orbital path, enabling him to direct the astronauts exactly where to point the camera at any given moment.

    Yair originally developed the experiment for the Columbia mission in 2003, alongside Israel’s first astronaut, Ilan Ramon, who successfully photographed sprites from space before the mission tragically ended with the shuttle’s disintegration. Since then, the experiment has been carried out several times aboard the ISS. In its current form, it was performed by Eytan Stibbe, Israel’s private astronaut on the Ax-1 mission in 2022 — with the Israeli segment named “Rakia Mission.”

    The Rakia Mission later became a public benefit corporation and helped facilitate the inclusion of the experiment in Axiom’s subsequent private missions. While the experiment ended in disappointment during Ax-2, it yielded interesting results in Ax-3. For Ax-4, it is being conducted in collaboration with Professor József Bór of the Hungarian Institute of Earth Physics and Space Science.

    5 View gallery

    Preparing to enter a cooling phase until next year. An illustration of the spacecraft during its close approach to the SunPreparing to enter a cooling phase until next year. An illustration of the spacecraft during its close approach to the Sun

    Preparing to enter a cooling phase until next year. An illustration of the spacecraft during its close approach to the Sun

    (Photo: Axiom Space)

    “Kapu is the astronaut designated to lead the experiment, but we conducted a video training session with the entire crew, and everyone expressed interest in participating and capturing these phenomena,” Yair told the Davidson Institute website. He and his colleagues supply forecast data to the astronauts and hope the crew will find time to document as many events as possible. “We’ve already recorded dozens of brief electrical discharges, but we’ve yet to capture Gigantic Jets — massive, high-temperature lightning events,” he noted.

    He also added that the camera used in the experiment doesn’t remain on the space station but travels with the astronauts on each mission. “That’s ideal, since it has had minimal exposure to cosmic radiation, which helps maintain high image quality.” The Israeli experiment is one of about 60 scientific and medical experiments planned for the AX-4 crew during their approximately two-week stay aboard the ISS.

    “The Rakia Mission has been supporting the Hungarian space mission over the past two years,” added Hadar Vernik Shalev, CEO of the Rakia Mission. “We advised them on astronaut selection, candidate screening, and the setup of their mission control room.”

    The mission of Indian astronaut Shubanshu Shukla is generating widespread public interest across the country, which is also developing its own crewed spaceflight program. Sending a representative to the ISS is seen as an important first step.

    “As part of Rakia’s efforts to support space missions, we partnered with CMS School in Lucknow, northern India — Shukla’s alma mater,” said Hadar Vernik Shalev to the Davidson Institute website. “We assisted in developing educational content, translating it into local languages, and establishing a mission control room and visitor center. We’re one of the few organizations globally with the expertise to support missions of this kind, and from our perspective, this collaboration with India is just the beginning.”

    A European company developing spacecraft intended for cargo — and eventually human — transport into Earth orbit has lost its uncrewed spacecraft at the end of a mission it described as a “partial success.” The spacecraft Mission Possible, developed by The Exploration Company, was launched last Monday aboard a SpaceX Falcon 9 rocket from Vandenberg Space Force Base in California, along with other payloads.

    5 View gallery

    Preparing to enter a cooling phase until next year. An illustration of the spacecraft during its close approach to the SunPreparing to enter a cooling phase until next year. An illustration of the spacecraft during its close approach to the Sun

    Preparing to enter a cooling phase until next year. An illustration of the spacecraft during its close approach to the Sun

    (Photo: SpaceX)

    Just under three hours after launch, Mission Possible separated from the rocket as planned and began a controlled re-entry over the northern Pacific Ocean. At that point, the spacecraft was operating normally, and mission control successfully activated several onboard experiments for in-space execution.

    The conical capsule, weighing 1.6 tons, survived atmospheric re-entry. Following a brief, expected signal loss caused by the intense heat and plasma buildup during the spacecraft’s re-entry, contact was reestablished. However, communication was lost again just minutes before the scheduled splashdown. The company suspects a malfunction in the parachutes may have caused the spacecraft to crash into the ocean.

    “We apologize to all our clients who entrusted us with their payloads,” the company said, adding that an investigation is underway into the root causes of the spacecraft’s loss.

    The company also stated that once findings are reviewed, it plans to move forward with a follow-up mission as soon as possible. Mission Possible was The Exploration Company’s second space mission. A year earlier, it launched a smaller demonstration craft that also faced setbacks — due to a second-stage malfunction during the maiden launch of the Ariane 6 rocket, the spacecraft became stranded in orbit and was unable to attempt atmospheric re-entry.

    The spacecraft lost last week was a prototype of Nyx, a vehicle the company is developing for orbital cargo transport. On June 16, at the Paris Air Show, the company also announced plans to develop a crewed version of the spacecraft.

    NASA’s Parker Solar Probe has completed another close flyby of the Sun, matching its previous flyby records for the closest approach to our star from December 2024 and March 2025, for both proximity and speed. The spacecraft came within just 6.2 million kilometers of the solar surface and reached a speed of approximately 690,000 kilometers per hour — equaling its own record for the fastest human-made object.

    5 View gallery

    Preparing to enter a cooling phase until next year. An illustration of the spacecraft during its close approach to the SunPreparing to enter a cooling phase until next year. An illustration of the spacecraft during its close approach to the Sun

    Preparing to enter a cooling phase until next year. An illustration of the spacecraft during its close approach to the Sun

    (Photo: NASA)

    This marked Parker’s 24th solar flyby since its launch in 2018 — and the final one in this phase of the mission. Last week, mission controllers confirmed a successful pass, with all instruments fully operational, its heat shields enduring extreme temperatures exceeding 900°C. Parker will now shift to a more distant orbit, with no close passes planned until a decision about the mission’s next phase is made sometime next year.

    The data collected during the spacecraft’s flybys of the Sun are used to study solar wind and solar flares—phenomena that affect satellite operations, spacecraft systems, and astronaut health in space. Gaining a better understanding of these events, along with the development of the ability to predict powerful solar outbursts, is critical for planning and advancing deeper space missions, to the Moon, Mars and beyond.

    “Parker Solar Probe remains in excellent health, with both the spacecraft and its instruments ready to continue their groundbreaking mission,” said Arik Posner, Parker Solar Probe program lead scientist. “The spacecraft will keep exploring the solar atmosphere as the Sun enters the declining phase of its 11-year cycle, providing a unique opportunity to study how solar activity evolves and shapes the heliosphere during this pivotal period.”

    The new U.S. observatory named after astronomer Vera Rubin has released its first public images, showcasing its capabilities after entering a trial phase about two months ago. Located in Chile and built over nearly three decades at a cost exceeding one billion dollars, the Vera Rubin Telescope’s debut images reveal its exceptional imaging quality.

    5 View gallery

    The world’s largest digital camera that will help unlock the secrets of the universe. The Vera Rubin Telescope at the summit of Cerro Pachón in Chile The world’s largest digital camera that will help unlock the secrets of the universe. The Vera Rubin Telescope at the summit of Cerro Pachón in Chile

    The world’s largest digital camera that will help unlock the secrets of the universe. The Vera Rubin Telescope at the summit of Cerro Pachón in Chile

    (Photo: RubinObs/NOIRLab/SLAC/NSF/DOE/AURA/P. Horálek (Institute of Physics in Opava))

    Equipped with an 8.4-meter primary mirror—not particularly large by today’s standards—the telescope’s true advantage lies in its state-of-the-art camera, roughly the size of a small car and weighing about three tons. Each image it captures is 3,200 megapixels in size, making it the world’s largest digital camera.

    The telescope features an exceptionally wide field of view—about 10 square degrees. Each image covers a portion of the sky roughly 45 times larger than the full Moon. Designed to take around 1,000 images per night, the telescope can survey the entire southern sky every three to four nights. This continuous, wide-field monitoring enables scientists to track changes and ongoing processes, detect previously unknown celestial objects, and, when needed, direct other telescopes toward them for follow-up observations.

    Researchers believe the telescope will identify more stars and planetary systems than any previous instrument, and will also significantly enhance planetary defense by detecting numerous asteroids, including those that could pose a future threat to Earth. Additionally, the observatory will contribute to research on cosmic mysteries such as dark matter and dark energy.

    The Vera Rubin Observatory will operate as part of a broad international scientific collaboration, working with a range of international partners. Among them is Israel’s ULTRASAT space telescope project, in development at the Weizmann Institute of Science and slated for launch in about two years.

    Like the Vera Rubin Telescope, ULTRASAT will have a wide field of view and repeatedly scan large portions of the sky—though in ultraviolet light, rather than in visible light, making the two projects scientifically complementary. As part of the partnership, U.S. scientists will gain access to ULTRASAT’s data, and Israeli researchers will be able to use data from the Vera Rubin Telescope


    Continue Reading

  • Tymek does an ERC3 treble

    Tymek does an ERC3 treble

    Having topped the ERC3 order on BAUHAUS Royal Rally of Scandinavia and on his home event, ORLEN OIL 81st Rally Poland, Abramowski secured a standout treble on Rally di Roma Capitale, which marked only his second start on asphalt.

    Hubert Kowalczyk finished second with Casey-Jay Coleman banking his maiden podium in third place.

    Hubert Kowalczyk on his way to finishing second

    © AT World

    “The last loop was crazy-slow but we had to do it to not risk any damage on the car or punctures,” said Abramowski, who extended his ERC3 points lead and also topped the ERC Fiesta Rally3 Trophy classification. “We took it very slowly, moreover we had some brake failure, so we had to take it carefully to finish the rally. Three wins in a row is amazing and we want to continue like this.”

    Abramowski, who turns 19 tomorrow (Monday), began Sunday’s deciding leg 3.2sec behind his fellow Pirelli-equipped Ford Fiesta Rally3 driver Tristan Charpentier. But second became first when Charpentier retired on SS9 with a mechanical issue to leave Abramowski almost two minutes in front of fellow Pole Kowalczyk.

    While Taylor Gill went on a stage-winning spree following his restart on Sunday morning, Abramowski focused on preserving his comfortable advantage to the finish alongside co-driver Jakub Wróbel.

    Casey-Jay Coleman claimed his maiden ERC3 podium in Rome

    Casey-Jay Coleman claimed his maiden ERC3 podium in Rome

    © At World

    “We was fighting quite tight so it’s a shame for [Charpentier] but it meant we were leading by two minutes, which is quite a lot. But we had to think a lot about the car because it’s not like you can push everything everywhere.”

    Kowalcyk took second aboard his Chmielewski Motorsport-run Renault Clio Rally3 with Coleman taking a strong third at the wheel of a Fiesta Rally3.

    “We are happy we are here at the finish,” said Kowalczyk. “It was a good, clean rally, we had some problems but finally I am happy.”

    Coleman said: “First time here, I’m delighted. Obviously it was a tough rally with the heat so it was a big challenge but anytime you are on the podium it’s a good day. We got a [front-left] puncture on the first stage out of service this afternoon and we only had one spare so that had our hearts in our mouths for a while. It was four kilometres from the end and we had to drive on the rim.”

    “First time here, I’m delighted. Obviously it was a tough rally with the heat so it was a big challenge but anytime you are on the podium it’s a good day.”

    Swedish teenager Adam Grahn finished his first Tarmac rally in fourth place with Błażej Gazda fifth. Sebastian Butyński was on course to complete the top six behind his Chmielewski Motorsport team-mate but stopped on the penultimate stage to hand the position to Martin Ravenščak, who overcame myriad mechanical issues to finish sixth.

    Hubert Kowalski restarted following his SS4 retirement to finish seventh, one place ahead of Taylor Gill, who was fastest on all six stages today after he dropped out of the lead following SS3 with a fuel pump failure.

    “It was nice to be back out and find a bit of a rhythm,” said FIA Junior WRC leader Gill. “We’ve been trying to build our Tarmac experience and that’s what we’re here for. Obviously retiring yesterday means there’s nothing more we can do than just drive and build the experience. But it’s a really nice rally and a mega challenge.”

    ERC Rally di Roma Capitale 2025, Gill

    ERC Rally di Roma Capitale 2025, Gill

    © ERC

    Laskowski, whose Rally di Roma Capitale debut was made possible after 2022 ERC3 champion Igor Widłak gave him the use of his Ford Fiesta Rally3, said of his Saturday exit.

    “The corner was too tight, we had a little bit of gravel and my line was not very good and we hit a stone on the exit of the corner and broke the left rear wheel. The pace before it was very good for the first time but the corner was too tight and that’s rally.”

    After winning SS1 on the streets of Rome on Friday night, Adrian Rzeźnik retired with electronics failure on SS3. He returned to the action on Sunday morning but went off the road on SS12 having set several strong tyres during co-driver Kamil Kozdroń’s 130th rally.

    Barum Czech Rally Zlín is up next on the ERC schedule from 15 – 17 August.

    Continue Reading